Neurogene (NGNE) Long-Term Investments (2014 - 2017)

Neurogene (NGNE) has 4 years of Long-Term Investments data on file, last reported at $20.0 million in Q1 2017.

• Quarterly Long-Term Investments fell 48.2% year-over-year to $20.0 million in Q1 2017, while the trailing twelve-month figure through Mar 2017 was $20.0 million (down 48.2% YoY) and the FY2016 annual result came in at $50.0 million, up 30.13% from the prior year.
• Long-Term Investments slipped to $20.0 million in Q1 2017, from $50.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $50.0 million in Q4 2016 to a low of $2.0 million in Q4 2014.
• A 4-year average of $24.8 million and a median of $20.0 million in 2017 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2015 — Long-Term Investments jumped 1820.02% — and 2017, when it tumbled 48.2%.
• Tracing NGNE's Long-Term Investments over 4 years: stood at $2.0 million in 2014, then jumped by 1820.02% to $38.5 million in 2015, then surged by 30.13% to $50.0 million in 2016, then tumbled by 60.02% to $20.0 million in 2017.
• The last three Long-Term Investments figures came in at $20.0 million (Q1 2017), $50.0 million (Q4 2016), and $16.7 million (Q3 2016), per Business Quant data.